34 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
(a)(ii) of the Seller Disclosure Schedule, together with the employer portion of all related FICA, state, local or foreign withholding, payroll, social … , slogans, trade dress and brands, domain names or online or other electronic identifiers, social media names, tags or handles, service names, or other
8-K
EX-99.1
s2ticuarxr89kfj
27 Oct 23
Regulation FD Disclosure
4:19pm
424B3
regvqnuurte3
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
8ean ij0ads
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
pwuy313 ydeff9kughv
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
f6f7g5fn3sqj9v4z
16 Jun 23
Business combination disclosure
8:08am
425
s75ay5t4shqvztnybo9c
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
luwnuuma
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
424B5
64sadn n0
17 Nov 22
Prospectus supplement for primary offering
5:37pm